Want to see VNRX full AI Analyst Report?
VolitionRX (VNRX) Stock Statistics & Valuation Metrics
Total Valuation
VolitionRX has a market cap or net worth of $5.45M. The enterprise value is $19.60M.
- Market Cap
- $5.45M
- Enterprise Value
- $19.60M
Share Statistics
VolitionRX has 27,903,326 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,903,326
- Owned by Insiders
- 52.03%
- Owned by Institutions
- 0.84%
Financial Efficiency
VolitionRX’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 1236.74%.
- Return on Equity (ROE)
- 0.68
- Return on Assets (ROA)
- -3.38
- Return on Invested Capital (ROIC)
- 1236.74%
- Return on Capital Employed (ROCE)
- 3.98
- Revenue Per Employee
- 30.30K
- Profits Per Employee
- -409.77K
- Employee Count
- 57
- Asset Turnover
- 0.25
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of VolitionRX is -0.05. VolitionRX’s PEG ratio is -0.00.
- PE Ratio
- -0.05
- PS Ratio
- 0.96
- PB Ratio
- -0.06
- Price to FCF
- -0.12
- Price to Operating Cash Flow
- -0.09
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, VolitionRX had revenue of 1.73M and earned -23.36M in profits. Earnings per share was -4.40.
- Revenue
- 1.73M
- Gross Profit
- 1.73M
- Operating Income
- -21.22M
- Pretax Income
- -23.50M
- Net Income
- -23.36M
- EBITDA
- -19.80M
- Earnings Per Share (EPS)
- -4.40
Cash Flow
In the last 12 months, operating cash flow was -19.40M and capital expenditures -20,791, giving a free cash flow of -19.43M billion.
- Operating Cash Flow
- -19.40M
- Free Cash Flow
- -19.43M
- Free Cash Flow per Share
- -2.12
Dividends & Yields
VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -776.90%
- Earnings Yield
- -1349.09%
Stock Price Statistics
- Beta
- 0.75
- 52-Week Price Change
- -97.76%
- 50-Day Moving Average
- 0.27
- 200-Day Moving Average
- 2.10
- Relative Strength Index (RSI)
- 40.30
- Average Volume (3m)
- 8.69M
Important Dates
VolitionRX upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
VolitionRX as a current ratio of 0.17, with Debt / Equity ratio of -33.48%
- Current Ratio
- 0.17
- Quick Ratio
- 0.17
- Debt to Market Cap
- 0.39
- Net Debt to EBITDA
- -0.52
- Interest Coverage Ratio
- -8.53
Taxes
In the past 12 months, VolitionRX has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
VolitionRX EV to EBITDA ratio is -0.71, with an EV/FCF ratio of -0.60.
- EV to Sales
- 4.75
- EV to EBITDA
- -0.71
- EV to Free Cash Flow
- -0.60
- EV to Operating Cash Flow
- -0.60
Balance Sheet
VolitionRX has $2.79M in cash and marketable securities with $11.97M in debt, giving a net cash position of -$9.18M billion.
- Cash & Marketable Securities
- $2.79M
- Total Debt
- $11.97M
- Net Cash
- -$9.18M
- Net Cash Per Share
- -$0.33
- Tangible Book Value Per Share
- -$3.70
Margins
Gross margin is 89.65%, with operating margin of -786.69%, and net profit margin of -1043.11%.
- Gross Margin
- 89.65%
- Operating Margin
- -786.69%
- Pretax Margin
- -1046.83%
- Net Profit Margin
- -1043.11%
- EBITDA Margin
- -671.41%
- EBIT Margin
- -717.36%
Analyst Forecast
The average price target for VolitionRX is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 86.32%
- EPS Growth Forecast
- 21.31%
Scores
- Smart Score
- ―
- AI Score
- 45
